UAB To Test Potential COVID-19 Vaccine
By BirminghamWatch
The University of Alabama at Birmingham and the biopharmaceutical company Altimmune Inc. will test a potential vaccine for COVID-19, the university announced today.
Testing of the vaccine, AdCOVID, which was developed by the company based in Gaithersburg, Maryland, will begin in mice during the second quarter of this year. That phase of testing, designed to show the immune response to the drug in mice, is expected to take one to two months, UAB said in announcing the collaboration.
The vaccine is given in a single dose of intranasal spray, UAB said. If results of the tests in mice warrant, Altimmune could launch a Phase 1 human safety trial during the third quarter of this year.
The announcement by UAB said Altimmune “has significant experience in the development of intranasal vaccine candidates for respiratory pathogens, including a seasonal and pandemic influenza vaccine and a vaccine for inhalation anthrax.”
“We are eager to collaborate with Altimmune on this important project,” said Frances E. Lund, the Charles H. McCauley Professor and Chair for the UAB Department of Microbiology. “The expertise and infrastructure at UAB will be invaluable to the rapid progression of this vaccine into clinical studies.
Lund said six labs at UAB will work on the project.
Vipin K. Garg, president and CEO of Altimmune, cited UAB’s role in research in virology and immunology. He said the company was founded through a technology license from UAB in 1997.
“It is critical that the biotechnology industry and academic institutions work together to prevent the further spread of COVID-19, and UAB is an ideal partner to support us in this effort,”Garg said.
UAB also has extensive experience in conducting clinical studies of vaccines and has participated in studies sponsored by the Vaccine Evaluation and Trial Unit, part of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.
The vaccine being tested “will activate mucosal and cellular immune responses, as well as a strong antibody response in the blood,” the announcement said.
“If the AdCOVID vaccine candidate is as stable as Altimmune’s influenza and anthrax vaccines candidates, that may allow inexpensive and efficient distribution of the millions of doses needed for widespread vaccination of populations,” the statement said.
UAB building among Alabama’s first to feature ‘bird safe’ glass
Advocates hope the new glass will prevent window collisions, a leading causes of bird mortality.
Researchers look into community health impact of wood pellet production in rural Mississippi
Brown University and Tougaloo College students are testing for potential air and noise pollution near the Drax wood pellet plant in Gloster, Mississippi.
Alabama coal company sued for a home explosion is delinquent on dozens of penalties
Crimson Oak Grove Resources has been cited for 204 safety violations since the March 8 blast, many involving “significant and substantial” safety violations.
The United Auto Workers faces a key test in the South with upcoming vote at Alabama Mercedes plant
The United Auto Workers is aiming for a key victory at Mercedes-Benz in Alabama. More than 5,000 workers at the facility in Vance and nearby battery plant will vote this week on whether to join the UAW.
Gambling, ethics bills fall short as legislative session ends
Alabama lawmakers closed the books on this year’s regular legislative session Thursday. While Republican leaders passed many of their priority bills, perhaps the most talked about issue – gambling – died.
A look at what passed and failed in the 2024 legislative session
Alabama lawmakers have ended a 2024 legislative session that saw the Republican majority win approval for a number of their top priorities.
